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Sulfate conjugating and transport functions of MDCK distal and kidney [1–3], with reported renal values of 2% to
tubular cells. 20% compared to the liver [4–8]. This could account for
Background. Transfected Madin-Darby canine kidney the lack of interest in the study of renal sulfate conjuga-(MDCK) cells (of distal tubular origin) have been used to study
tion [9]. The enzyme phenolsulfotransferase (PST) hastransport of organic anions. These cells have not been shown
been demonstrated in kidneys of various experimentalto possess sulfate-conjugating activity. Neither has transport
activity been demonstrated in nontransfected MDCK cells. animals from our laboratory [10, 11] and in human fetal
Methods. Polarized and monolayers of nontransfected MDCK and adult kidneys [12]. The only PST isoform reported
type II cells were incubated with prototype substrates of phe-
to be expressed in human kidney is SULT1C1 [13].nolsulfotransferase (PST) and sodium sulfate in the absence
On the other hand, all isoforms of organic anion trans-or presence of known inhibitors of multidrug resistance protein
(MRP): (3-3-(2-(7-chloro-2-quinionlinyl) ethenyl)phenyl)(3-di- porter (OAT), organic cation transporter (OCT), and
methylamino-3-oxopropyl)thio)methyl)thio) propanoic acid multidrug resistance protein (MRP) where tissue distri-
(MK571), cyclosporin A (CsA), and probenecid. Effects of bution has been examined, have been found in kidney
glutathione (GSH) and buthionine sulfoximine (BSO), poten-
[14–16]. These transporters play a crucial role in thetial modulators of the organic anion transporting protein/poly-
phase III elimination of the anionic conjugates. Thispeptide (OATP) isoform, OATP1 were also examined. Sul-
fated conjugates were identified by high-performance liquid highlights their potential contribution to the urinary ex-
chromatography (HPLC)-radiometry or HPLC-fluorimetry. cretion of endobiotics and xenobiotics.
Results. Uptake, sulfate conjugation, and efflux of the sul- This paper is the first report to demonstrate sulfatefated conjugates of harmol, p-nitrophenol, N-acetyldopamine
conjugation and subsequent transport of a number ofand acetaminophen were demonstrated. Activities in MDCK
type II cells were higher than those in HepG2, human fetal sulfated conjugates out of Madin-Darby canine kidney
liver, and Chang liver cells. A significant decrease in extracellu- (MDCK) type II distal tubular cells. These activities were
lar with a reciprocal increase in intracellular harmol sulfate higher than those in HepG2, Chang liver, and human
was observed with MK571, CsA, and probenecid and with
fetal liver cells. Hitherto, only proximal tubular cells ofpreloading of glutathione. Depletion of intracellular glutathi-
kidneys were thought to be endowed with such activities.one by BSO had the opposite effects.
Conclusions. Normal (nontransfected) MDCK type II cells Both MRP and organic anion transporting protein/poly-
provide a suitable system for the study of the physiologic pro- peptide (OATP), reported to be present on the apical
cesses of uptake, sulfate conjugation, and transport of sulfated membranes of kidney cells [14–20] are tentatively identi-conjugates in kidney cells. Based on the action of specific inhibi-
fied as responsible for the transport of harmol sulfatetors and modulators of MRP2 and OATP1, it was concluded
and other sulfated conjugates. Our study with MDCKthat MRP2-like and OATP1-like transporters are possibly re-
sponsible for the transport of sulfated conjugates. type II cells provides a model system for the study of
uptake and sulfation cum transport, which reflects se-
quential physiologic metabolic processes in normal kid-
Sulfate and glucuronide conjugations are two major ney cells.
phase II reactions in humans. Quantitatively, glucuro-
nide conjugation appears to predominate in both liver
MATERIALS
Sodium 35sulfate (specific activity of 540.37 mCi/mmol)Key words: MDCK cells, sulfate conjugation, transporters, MRP, OAT,
harmol, MK571. was purchased from DuPoint, NEN, Boston, MA, USA.
N-acetyldopamine, acetaminophen, p-nitrophenol, harmol,Received for publication March 28, 2002
cyclosporin A (CsA), glutathione (GSH), glutathioneand in revised form July 7, 2002, and September 6, 2002
Accepted for publication October 16, 2002 ethyl ester (GEE), probenecid, and methotrexate were
purchased from Sigma Chemical Co. (St. Louis, MO, 2003 by the International Society of Nephrology
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USA). MK-571 was a gift from Merck-Frosst, Canada. mmol/L, were used. Residual harmol was removed by
adding 120 L sodium phosphate buffer (pH 9.5) to theMDCK type II cells and human fetal liver cells were
gifts from Dr. Walter Hunziker of the Institute of Molec- reacted incubate, followed by extraction two times with
0.4 mL ethyl acetate. This step was introduced essentiallyular Cell Biology and Professor K.H. Sit of the Depart-
ment of Anatomy, National University of Singapore, to reduce the chromatographic time. The reaction was
carried out at 37C and terminated by precipitation ofrespectively. Transwell inserts (P/N 3401) were pur-
chased from Costar, Cambridge, MA, USA. Tissue cul- inorganic sulfate and proteins with 30 L each of 0.3
mol/L zinc sulfate and 0.3 mol/L barium hydroxide. Fol-ture flasks were obtained from Nunclon (Resklide, Den-
mark). Fetal bovine serum (FBS) was obtained from lowing centrifugation, the supernatant was passed through
a 0.4 m filter and aliquots were analyzed for harmol sul-Trace Bioscience, Pty., Ltd., Castle Hill, New South
Wales, Australia and the antibiotic/antimycotic mixture fate by high-performance liquid chromatography (HPLC)-
fluorimetry. For the radiolabeled sulfated conjugates, sep-was purchased from Gibco (Grand Island, NY, USA).
aration and quantification was by HPLC radiometry.
Overall sulfate conjugation cum transport in monolayerMETHODS
cells. The overall sulfation cum transport was studied
Cell cultures with the substrates mentioned at concentrations given
MDCK type II, human fetal liver, HepG2, and Chang above. Approximately 1.5  105 cells were seeded into
liver cells were purchased from American Type Culture each well of a 12-well plate 1 day before use. The medium
Collection (ATCC) were cultured in monolayer in Dul- was removed and the cells were washed with 1  phos-
becco’s Modified Eagle Medium (DMEM) supple- phate-buffered saline (PBS) solution. One milliliter of
mented with 10% FBS in a humidified incubator (5% loading buffer, containing the reaction mixture in Hank’s
CO2, 37C) balanced salt solution (HBSS)/glucose, was added to
each well. The plate was then incubated at 37C for 1
Assay conditions hour. The extraction step with ethyl acetate as described
Overall sulfation in cell lysate. The cell lysate was pre- above was only applied to the assays with harmol as
pared by harvesting confluent cells in 0.15 mol/L potas- substrate. The external medium was removed quantita-
sium chloride containing 3 mmol/L dithiothreitol (DTT); tively, precipitated as described above with zinc sulfate
it was stored frozen at –80C until ready to use. It was and barium hydroxide, and filtered. The cells remaining
used for measuring the overall sulfate conjugation reac- in the wells were washed and lysed with 1 mL distilled
tions (i, ii and iii) with harmol, p-nitrophenol, N-acetyl- water and sonicated for 1 minute before adding 10 L
dopamine and acetaminophen as substrates. 70% perchloric acid, followed by centrifugation and fil-
tration. Measurement of intracellular harmol sulfate inATP sulfurylase
the cell lysates and harmol sulfate in the incubating me-
(i) SO4  ATP → APS  PPi dium was by HPLC fluorimetry while the radiolabeled
sulfated conjugates formed from 0.1 mmol/L sodiumAPS kinase
35sulfate were measured by HPLC-radiometry. The intro-
(ii) APS  ATP → PAPS  ADP duction of inhibitors and other chemicals are as specified
in individual experiments.PST
Transport studies of harmol sulfate using polarized
(iii) PAPS  substrate → Sulfated substrate  PAP MDCK type II cells. Approximately 1.6  105 cells were
seeded on Transwells covered with a polycarbonatewhere ATP is adenosine 3-triphosphate, APS is adeno-
membrane of 0.4 m pore size (Costar P/N3401). Thesesine 3-phosphosulfate, PPi is pyrophosphate, PAPS is
were inserted into a 12-well plate. The upper and lower3-phosphoadenosine 5-polysulfate, and PST is phenol-
compartments were filled, respectively, with 0.4 mL andsulfotransferase.
1.0 mL medium. The medium was changed on the secondAll reactions were carried out in 50 mmol/L KH2PO4/
and fourth day followed by monitoring the tightness ofNaOH buffer at pH 7.4 with the following substrates:
gap junction for 4 hours after removing the medium from2.5mol/L p-nitrophenol, 20mol/L N-acetyldopamine,
the lower compartment. The medium was then discarded2 mmol/L acetaminophen, and 1 mmol/L harmol. These
and the cells were washed with 1  PBS. Basolateral oroptimal concentrations were based on kinetics obtained
apical loading of various chemicals was as stated in thewith liver cells (data not shown). Each of these substrates
individual sets of experiments described below. The platewas co-incubated with 0.1 mmol/L sodium 35sulfate and
was then incubated at 37C for 1 hour. The external5 mmol/L each of ATP and MgCl2 in a final volume of
media from both compartments, as well as the cell ly-200 L; these concentrations were based on previous
sates, processed as described above for monolayer cells,studies from our laboratory [21–23]. In the fluorimetric
assay, harmol and unlabeled sodium sulfate, each at 1 were analyzed in the same manner by HPLC fluorimetry.
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Table 1. Separation of radiolabeled sulfated conjugates from sodium ODS (Hewlett-Packard) of 5 m particle size. The
35sulfate, by high-performance liquid chromatography (HPLC)-
amount of sulfate conjugate formed was determined byradiometry and harmol sulfate from harmol by HPLC-fluorimetrya
extrapolating from a standard curve of 1.6 pmol – 22.4
Retention time minutes
Mobile pmol sodium 35sulfate, which showed a linear detector
phase Sulfate conjugate of Sodium35 sulfate Harmol response.
A p-Nitrophenol 7.5 2.1 — Harmol sulfate was also detected and quantified by
B N-acetyldopamine 5.7 1.7 — HPLC-fluorimetry. The system consisted of a Hewlett
C Acetaminophen 3.4 1.7 —
Packard 1050 system attached to an Hewlett PackardD Harmol 5.9 2.4 —
E* Harmol 2.6 10.5 1046 fluorescence detector. Measurements were made
a A flow rate of 1 mL/min was employed using a column of 4.6  200 mm, at excitation wavelength of 310 nm and emission of 420
except in mobile solvents C and E, where a 2.1  100 mm column was used nm. As harmol sulfate is not commercially available,with a flow rate of 0.5 and 0.3 mL/min, respectively.
A, 75 mmol/L NaH2PO4, 1 mol/L EDTA and 0.35 mmol/L 1-octanesulfonic results are expressed as “harmol equivalents” from a
acid adjusted to pH 4.0, plus 4% acetonitrile and 11% methanol. standard curve of harmol of 20 pmol to 100 pmol.B, Same as A but with 2% methanol.
C, 20 mmol/L KH2PO4 and 1 mmol/L EDTA adjusted to pH 7.0 and 4%
methanol. Comparative studies of sulfate conjugating and sulfate
D, 20 mmol/L KH2PO4 and 2.5 mmol/L octylsulfate adjusted to pH 3.5 and conjugating cum transport activities between kidney35% methanol.
E, Same as D but with 50% methanol. and liver cells
The overall sulfate conjugation was measured in cell
lysates and sulfate conjugation cum transport was mea-
sured in monolayers of MDCK type II, HepG2, humanHarmol sulfate was synthesized in vitro in a similar
fetal liver, and Chang liver cells. The protein contentreaction as described above using rat liver cytosol. An
was determined by the Bradford method [25].extended incubation of 2 hours was used. Harmol sulfate
was separated from harmol by gel filtration with Sepha-
dex G-25, following the procedure reported previously RESULTS
from our laboratory [24]. Quantification of the preformed Sulfate conjugation in lysates of MDCK type II cells
harmol sulfate was by HPLC-fluorimetry and extrapo-
Lysates prepared from MDCK type II cells were ablelated from a standard of harmol. In two different sets
to form sulfated conjugates of p-nitrophenol, N-acetyl-of experiments, the basolateral compartment was loaded
dopamine, acetaminophen, and harmol from sodiumin a final volume of 1 mL HBSS/glucose, pH 7.4 contain- 35sulfate and ATP. Under the same condition of assay,
ing (a) 0.01 mmol/L preformed harmol sulfate and (b)
the specific activities of the overall sulfate conjugation
1 mmol/L each of harmol and sodium sulfate. (3-3-(2-(7- reaction for these substrates are shown in Figure 1. These
chloro-2-quinionlinyl)ethenyl)phenyl)(3-dimethyl-amino- values were calculated from a standard of sodium 35sul-
3-oxopropyl)thio)methyl)thio)propanoic acid (MK571) fate determined at the same time by HPLC-radiometry.
(25mol/L) was introduced into the apical compartment The chromatographic conditions and retention times are
in both experiments. Incubation was carried out for 1 shown in Table 1.
hour at 37C and harmol sulfate was measured in the The sulfation of harmol with unlabeled sodium sulfate
apical compartment for experiment (a) and in the apical was also measured but by HPLC-fluorimetry. The reten-
and basolateral compartments for experiment (b) and tion times of harmol and harmol sulfate are also shown
intracellular compartments for both. in Table 1. The overall sulfation of harmol in lysates of
renal tubular cells of MDCK type II showed Michaelis-HPLC radiometry and HPLC fluorimetry
Menten kinetics measured with 0.02 mmol/L to 2 mmol/L
The radiolabeled sulfated conjugates of p-nitrophenol, sodium sulfate and 1.5 mol/L to 200 mol/L harmol
N-acetyldopamine, acetaminophen and harmol were de- and the overall rate of reaction was linear for cell lysate
tected and quantified by an HPLC system (Hewlett- containing up to 0.4 g protein/assay incubate (data not
Packard 1090, Hewlett-Packard, Waldbronn, Germany) shown).
connected to a radioactivity detector (Flo-one/Beta, Pack-
Sulfate conjugation cum transport in MDCKard Instrument Co, Inc., Downers Grove, IL, USA). A
type II monolayerssolid cell of 250 L volume packed with calcium fluo-
ride was used. For ease of reference, the different solvent The overall sulfation of harmol, p-nitrophenol, N-acet-
systems used in the separation of the sulfated conjugates yldopamine and acetaminophen, followed by efflux of
from sodium 35sulfate are shown in Table 1 together with the respective sulfated conjugates was also demonstrated
their retention times. Unless otherwise stated, the mobile in MDCK type II monolayer cells, without added ATP,
phase was delivered at 1 mL/min through a C18 column indicating their ability to form “active sulfate” from so-
dium sulfate. A comparison of the combined activity of(2.1  100 mm or 4.6  200 mm) packed with Hypersil-
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Fig. 1. Overall sulfate-conjugating activities
in cell lysates of Madin-Darby Canine Kidney
type II (MDCKII) cells compared to HepG2,
human fetal liver, and Chang liver cells mea-
sured with different substrates. Values are
means  SD from triplicates and are ex-
pressed in picomole sulfate conjugates min1
mg protein1, extrapolated from a standard of
3 pmol to 22 pmol sodium35 sulfate.
Fig. 2. Measurement of uptake, sulfate con-
jugation and efflux of the sulfated conjugates
in monolayers of Madin-Darby Canine Kid-
ney type II (MDCKII), HepG2, human fetal
liver, and Chang liver cells. The sulfate conju-
gates formed from p-nitrophenol (2.5 mol/L),
N-acetyldopamine (20 mol/L), acetamino-
phen (2 mmol/L), and harmol (1 mmol/L) with
0.1 mmol/L sodium35 sulfate were separated
from sodium 35sulfate by high-performance
liquid chromatography (HPLC)-radiometry
(see Table 1 for chromatographic conditions
and retention times). A standard of 1.6 pmol
to 12.8 pmol sodium35 sulfate similarly mea-
sured at the same time was employed for the
quantitative analysis. Values are expressed in
means SD in nmol sulfated 35sulfated conju-
gate formed mg protein1 h1 (N  3).
uptake of various substrates, followed by sulfate conjuga- As the fluorimetric assay with harmol provides a sim-
ple and inexpensive assay procedure, it was preferred intion, and finally efflux of the sulfated products is shown
in Figure 2. Experiments carried out with preincubation subsequent experiments. In addition, nonradiolabeled
sodium sulfate could be employed at a concentration 10of substrates (an attempt to facilitate their uptake), fol-
lowed by sodium sulfate, showed essentially similar re- times higher in the fluorimetric assay. The kinetics of
intracellular accumulation and efflux of harmol sulfatesults as co-incubation of both. This seemed to suggest
that the uptake of the substrates did not influence the are shown in Figure 3. The rate of accumulation of the
conjugate inside the cells was low compared to that ofkinetics of reaction measured.
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trols (Fig. 4A). This was accompanied by an apparent
decrease (although not statistically significant) in the me-
dium. However, at a higher concentration of 5 mol/L,
MK-571 elicited a more significant accumulation and a
significant decrease of harmol sulfate in the efflux me-
dium (Fig. 4B). Likewise, CsA at 20 mol/L and proben-
ecid at 1 mmol/L produced a significant increase in intra-
cellular accumulation of harmol sulfate (Fig. 4 C and D).
The observation of a significant increase in intracellular
accumulation of harmol sulfate and its reciprocal de-
crease in the efflux medium on exposure to MK571, CsA,
and probenecid suggests that MRP-like transporter/s are
responsible for the efflux of harmol sulfate. In each in-
stance, there was no change in the “total” (sum of intra-
and extracellular) harmol sulfate, indicating that the over-
Fig. 3. Time course of accumulation of intracellular (), efflux (), all sulfate conjugation reaction was not compromised.and overall () of harmol sulfate by Madin-Darby Canine Kidney type
Glutathione-ethyl ester and buthionine sulfoximineII (MDCKII) monolayer cells following exposure to 1 mmol/L each of
harmol and sodium35 sulfate. The “overall” represents the sum of ac- (BSO). Glutathione-ethyl ester (GEE) is a permeant
cumulated and effluxed harmol sulfate measured at each time point. form of glutathione [28]. Preloading with GEE at 20Values are average of duplicates. Harmol sulfate was quantified by high-
mmol/L for 15 minutes prior to the assay of sulfationperformance liquid chromatography (HPLC) fluorimetry and values are
expressed as nmol harmol equivalents/106 cells in means  SD. cum transport resulted in a significant decrease (40%) in
extracellular harmol sulfate (Fig. 5A). Conversely, deple-
tion of glutathione by preincubation with 50 mol/L BSO
for 16 hours produced a significant increase in the ef-
the efflux measured up to 2 hours. The sum of extracellu- fluxed harmol sulfate and a reciprocal decrease in intra-
lar and intracellular harmol sulfate increased progres- cellular accumulation (Fig. 5B). The opposing effects of
sively from 1 hour to 2 hours, even though there was GEE and BSO on the transport and accumulation of
little further accumulation of harmol sulfate during this harmol sulfate suggest that the glutathione/organic anion
period (Fig. 3). exchanger (or OATP1), located on the luminal mem-
brane of renal cells, may also be involved in the transport
Comparison between renal and hepatic cells of harmol sulfate.
Combination of MK571 and glutathione-ethyl ester.Interestingly, monolayer MDCK type II distal tubular
The combined exposure to MK571 and GEE producedcells showed higher sulfate conjugating cum transport
an additive effect (Fig. 6), which was more significantactivity compared to HepG2, human fetal liver, and
than when each of these compounds was added aloneChang liver cells, measured with almost all the substrates
(Figs. 4A and 5A). Both the decrease in harmol sulfatestudied (Fig. 2). This was also evident in the overall
in the medium and the reciprocal increase in intracellularsulfate-conjugating activities determined in cell lysates
compartment were significantly different from the corre-(Fig. 1) with the exception of a higher activity for human
sponding controls (Fig. 6). The total harmol sulfate (sumfetal liver cells measured with N-acetyldopamine. The over-
of extracellular and intracellular) remained relatively un-all sulfate conjugation of harmol, measured in the lysate
changed; these compounds therefore had no effect onof MDCK type II cells by HPLC-radiometry (Fig. 1) and
the overall sulfation reactions.HPLC-fluorimetry (data not shown) was three to four
Methotrexate. Besides the MRP2 and glutathione/times higher than that of HepG2 cells. This was an unex-
organic anion exchanger, OATK1/K2, has been identi-pected observation, as generally the liver is considered
fied in the apical membrane of kidney tubules. This iso-to be the main organ for detoxification.
form has a narrow substrate specificity [29, 30]. Metho-
trexate is a known substrate of OATK1/K2 [31, 32].Effects of inhibitors/substrates/modulators of
Methotrexate at 5 mol/L had no effect on sulfation
transporters on harmol sulfation cum transport
cum transport of harmol (Fig. 7). It seems unlikely that
MK571, CsA, and probenecid. The effects of three OATK1/K2 is involved in the transport of harmol sulfate.
known specific inhibitors of MRP, namely MK571, CsA,
Transport of harmol sulfate in polarized cellsand probenecid [14, 15, 26, 27] were examined on MDCK
type II cells grown in monolayers. On exposure to 2.5 Uptake of preformed harmol sulfate by polarized cells
mol/L of MK571, there was a significant accumulation from the basolateral compartment was evident by its
appearance in the apical compartment showing transcel-of harmol sulfate intracellularly, compared to the con-
Ng et al: Sulfate conjugating and transport functions of MDCK cells 981
Fig. 4. Effects of (A ) 2.5 mol/L MK571 ( ) and control (), (B ) 5 mol/L MK571 ( ) and control (), (C ) 20 mol/L cyclosporin A ( )
and control (), and (D ) 1 mmol/L probenecid ( ) and control (), on sulfation cum transport of harmol sulfate. Harmol sulfate was determined
in the medium and in the cells following uptake of harmol and sodium sulfate, introduced at 1 mmol/L each to Madin-Darby Canine Kidney type
II (MDCKII) monolayer cells. The “total” represents the sum of the two. Values are expressed in means  SD (N  3). *P 	 0.01; **P 	 0.005;
***P 	 0.001
lular transport. The efflux through the apical membrane tal tubules include glutathione-S-transferase [33], steroid
was inhibited by MK571 (Fig. 8A), resulting in an in- 21-hydroxylase [34], phenylethanolamine N-methyltrans-
creased accumulation intracellularly. Harmol sulfate, ferase [35], catechol-O-methyltransferase [36] and N-ace-
formed from harmol and sulfate introduced in the baso- tyltransferase [37]. Interestingly, all glutathione-S-trans-
lateral compartment, was detectable in both the apical ferase enzymes showed intense expression in the distal
and basolateral compartments. The transport was again tubules [38]. Our preliminary studies on glutathione con-
inhibited by MK571, leading to a significant accumula- jugation with monochlorobimane, using MDCK type II
tion of intracellular harmol sulfate (Fig. 8B). cells corroborated this last observation. Because of the
strategic location of the proximal tubule in the nephron,
it is conceivable that it participates more actively in de-DISCUSSION
toxification as it is exposed to the initial filtrate of theThe proximal tubules of the kidney are thought to be
glomerulus. However, the distal tubule could provide amore metabolically active compared to the distal tubules
backup system. This is particularly relevant as sulfate[8]. Thus, most studies to date had been carried out with
conjugation is a system of low capacity [39], being limitedproximal tubular cells. However, our study has shown
by the bioavailability of the “active sulfate” or 3-phos-that, besides the proximal tubule, other nephron seg-
phoadenosine 5-phosphosulfate. Second, with the reab-ments such as the distal tubules of MDCK cells could
sorption of water in the distal tubule, any molecule thatpossess substantial sulfation and transport activities.
Other drug-metabolizing enzymes reported in the dis- has escaped biotransformation in the proximal tubule
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Fig. 6. Combined effects of preexposure to 20 mmol/L glutathione
ethyl ester (GEE) and control () for 15 minutes followed by co-
exposure of 2.5 mol/L MK571 ( ) and 1 mmol/L each of harmol and
sodium sulfate. Harmol sulfate was measured in the external medium
and intracellularly in treated and untreated Madin-Darby Canine Kid-
ney type II (MDCKII) monolayer cells. Values are means  SD (N 
3). *P 	 0.005.
Fig. 5. Effects of increase and depletion of intracellular glutathione,
(GSH), respectively, by preexposure to (A ) 20 mmol/L glutathione
ethyl ester (GEE) ( ) and control () for 15 minutes and (B ) 50
mol/L buthionine sulfoximine (BSO) ( ) and control () overnight
(16 hours) on the sulfation and transport of harmol sulfate by Madin-
Darby Canine Kidney type II (MDCKII) monolayer cells. Values are
means  SD (N  3). *P 	 0.05; **P 	 0.01
would be diluted. A high affinity system such as sulfate
conjugation [39] would be particularly advantageous.
Our study with MDCK type II cells, using a few sub-
Fig. 7. Effects of 5 mol/L methotrexate ( ) and control () on sul-strates, has demonstrated the sulfate conjugating and fation cum transport with harmol as substrate. No significant difference
transport functions of the distal tubular epithelia. The was observed in harmol sulfate in the extra- and intracellular compart-
ments between control and treated Madin-Darby Canine Kidney typecontribution of the distal tubules to the metabolic func-
II (MDCKII) cells. Values are means  SD (N  3).tion of the kidneys has, therefore, been overlooked both
with respect to sulfation (a major phase II detoxification
pathway in humans) and the subsequent transport or
excretion of the sulfated conjugates (representing the ized MDCK type II cells could also take up preformed
phase III elimination function of the kidney). Interest- harmol sulfate through the basolateral membrane and
ingly, both the sulfate conjugating and sulfate conjugat- its transport through the apical membrane could be in-
ing cum transport activities measured, respectively, in hibited by MK571. Previous studies from our laboratory
the lysates and monolayer cells were significantly higher had shown that kidneys from monkey, mouse, and dog
in MDCK type II cells compared to three other types exhibited higher activity in sulfation of isoprenaline and
of liver cells (HepG2, human fetal liver, and Chang liver harmol compared to the corresponding hepatic tissues
cells) in culture. In addition to uptake of harmol followed [10, 11]. Appreciable sulfation had also been reported
in isolated perfused kidneys [1, 40].by sulfation and efflux of harmol sulfate formed, polar-
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and with human MRP2 fused to green fluorescent pro-
tein (GFP) to its C-terminus [18, 20, 45]. However, en-
dogenous expression was not shown in nontransfected
MDCK and human embryonic kidney (HEK) cells [20],
suggesting that native expression may be too low for
detection. We had attempted to demonstrate transport
activity in the apical membrane by using MDCK polar-
ized cells and our results showed that the efflux activity
could be inhibited by MK571, a specific inhibitor of
MRP2 (Fig. 8 A and B).
Three inhibitors of MRP, specifically MK571, CsA at
micromolar concentration, and probenecid at millimolar
concentration, inhibited the efflux of harmol sulfate with
accompanying intracellular accumulation, suggesting that
MRP2 or MRP-like transporter/s may be responsible for
the transport of harmol sulfate. However, this does not
exclude other MRP isoforms present on the basolateral
membrane such as MRP1 [46]; this isoform shares a broad
substrate specificity with MRP2 [47]. Thus, MK571 and
CsA have also been shown to inhibit transport of p-amino-
hippurate (PAH) in membrane vesicles prepared from
MRP1- and MRP2- transfected cells [48]. Another baso-
lateral isoform, MRP3, is expressed at a very low level in
kidney [49]. The localization of other MRP isoforms are
Fig. 8. Transcellular transport of harmol sulfate. (A ) Preformed har-
not well characterized [14]. Thus, of the known MRPmol sulfate was introduced in the lower compartment of polarized
Madin-Darby Canine Kidney type II (MDCKII) cells grown on isoforms, MRP2, with its localization at the apical mem-
Transwell inserts. Harmol sulfate was measured in the upper (apical) brane [17–20], would more likely contribute to the excre-
compartment and intracellularly by high-performance liquid chroma-
tion of anionic conjugates in the urine. Interestingly,tography (HPLC)-fluorimetry. (B ) Inhibition of transport of harmol
sulfate synthesized intracellularly from 1 mmol/L each of harmol and chronic renal failure resulted in a specific overexpression
sodium sulfate in polarized Madin-Darby Canine Kidney type II of MRP2 in both kidney and liver. while the expression
(MDCKII) cells. When 25 mol/L MK571 ( ) was introduced in the
of the other apical multidrug transporter P-glycoproteinupper compartment there was intracellular accumulation of harmol
sulfate in both (A) and (B) as compared to controls ( ). Values are was unchanged [50]. Verapamil, a specific inhibitor of
means  SD (N  3). *P 	 0.01; **P 	 0.005. Abbreviations are: AP, MDR, when introduced at 0.1 mmol/L did not affect the
apical; BL, basolateral.
kinetics of harmol sulfation cum transport in our assay
system with MDCK type II monolayers (data not shown),
suggesting that the MDR transporter(s) may not be in-
volved.Harmol had been used as a substrate for both sulfate
and glucuronide conjugation [24, 41–43]. From pharma- In addition to the MRPs discussed above, the OATPs
form another family of multispecific organic anion trans-cokinetic studies, 70% of an administered dose of harmol
was excreted in the urine as harmol sulfate [44]. Extra- porters. Some OATP-related transporters include OATP1,
OATP2, and OATP3 [51–53] and the kidney-specifichepatic clearance of harmol appeared to contribute to
77% of total body clearance, suggesting that extrahepatic OAT-K1/K2 [29–32]. Although OATP was character-
ized as a basolateral transporter in liver [54], it was local-conjugation of harmol, possibly by the kidneys, could be
substantial [44]. Indeed, harmol was found to be a suit- ized to the apical membrane of the proximal tubules of
rat kidney [55]. The first evidence of the involvement ofable substrate for sulfate conjugation measured in MDCK
type II cell lysate (Fig. 1). The activity was three to four glutathione in the transport function of OATP came
from the observation that glutathione efflux might drivetimes higher than that of HepG2 cells (Fig. 1). Our aim
was to identify candidate transporters localized in the the uptake of organic anions such as the glutathione
conjugate of bromosulfophthalein (BSP), a known sub-apical membranes of MDCK type II cells, using harmol
as a substrate. The transporters, MRP2, OATP1 and strate of OATP [56]. Further reports on the trans-stimu-
lation between glutathione and certain organic solutesOATK1/K2 [15–17], are directly responsible for the se-
cretion and excretion of organic anions in the urine be- supported a role of glutathione [57, 58]. Glutathione
efflux provides the driving force for uptake of taurocho-cause of their luminal location. Localization of MRP2
and mrp2 was demonstrated in apical membrane of late into hepatocytes by OATP1 with a stoichiometry of
1:1 for the glutathione:taurocholate exchange [59]. OurMDCK-transfected cells using MRP2-specific antibody
Ng et al: Sulfate conjugating and transport functions of MDCK cells984
results on the transport of harmol sufate suggested that provide a convenient and robust cell system for the study
such an exchange system between harmol sulfate and of normal physiologic functions of renal cells in terms
glutathione may exist in MDCK type II cells. Preloading of uptake of substrates, followed by intracellular sulfate
the cells with GEE to increase intracellular glutathione conjugation, and the eventual efflux of the sulfated con-
demonstrated a significant intracellular accumulation of jugates. This normal system can also be used to examine
harmol sulfate, with a corresponding decrease in the the action of potential substrates, inhibitors, and modula-
medium. This was possibly due to an enhanced reuptake tors of transporter of sulfate conjugates. The ability of
of harmol sulfate aided by the higher glutathione content MDCK cells to differentiate into columnar epithelia to
in the cells that drives the OATP exchanger. Conversely, form tight junctions when cultured on semipermeable
BSO, which inhibits glutathione biosynthesis and thereby membranes is an added attractive feature for study of
depletes cellular glutathione, showed the opposite effect. directional transport. Polarized MDCK type II cells
The enhanced action of GEE and MK571 was probably grown for 4 days on Transwell inserts showed apical
the result of the combined effects of these compounds transport of harmol sulfate (both preformed and bio-
on the two transporters. As the effect of MK571 was synthesized from precurors harmol and inorganic sul-
partial (Fig. 4 A and B), the fraction of harmol sulfate fate); this efflux could be inhibited by MK571 introduced
transported out was taken back into the cells by the at the apical compartment. Recent reports had cautioned
glutathione-organic anion exchanger, OATP1. This re- that the loss of polarity in transfected cells could compro-
uptake of harmol sulfate was facilitated by GEE. mise their use in the study of vectorial transport [66, 67].
Two recent reports showed that parental non-trans- Our studies, however, were performed on normal non-
fected MDCK type II cells had negligible endogenous transfected MDCK type II cells.
expression of OATP8 and OATP2 compared to the cor-
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